211 related articles for article (PubMed ID: 7816085)
1. AIDS. Virological mayhem.
Wain-Hobson S
Nature; 1995 Jan; 373(6510):102. PubMed ID: 7816085
[No Abstract] [Full Text] [Related]
2. Reservoirs dog AIDS therapy.
Smaglik P
Nature; 2000 May; 405(6784):270-2. PubMed ID: 10830936
[No Abstract] [Full Text] [Related]
3. Immunologic and virologic markers determining progression to AIDS.
Schellekens PT; Koot M; Roos MT; Tersmette M; Miedema F
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S62-6. PubMed ID: 7552515
[TBL] [Abstract][Full Text] [Related]
4. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.
Markowitz M; Vesanen M; Tenner-Racz K; Cao Y; Binley JM; Talal A; Hurley A; Jin X; Chaudhry MR; Yaman M; Frankel S; Heath-Chiozzi M; Leonard JM; Moore JP; Racz P; Nixon DF; Ho DD
J Infect Dis; 1999 Mar; 179(3):527-37. PubMed ID: 9952358
[TBL] [Abstract][Full Text] [Related]
5. HIV results in the frame. Other approaches.
Bukrinsky M; Manogue K; Cerami A
Nature; 1995 May; 375(6528):195-6; author reply 198. PubMed ID: 7746316
[No Abstract] [Full Text] [Related]
6. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.
McCormick-Davis C; Dalton SB; Hout DR; Singh DK; Berman NE; Yong C; Pinson DM; Foresman L; Stephens EB
Virology; 2000 Jun; 272(1):112-26. PubMed ID: 10873754
[TBL] [Abstract][Full Text] [Related]
7. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
Ho DD; Neumann AU; Perelson AS; Chen W; Leonard JM; Markowitz M
Nature; 1995 Jan; 373(6510):123-6. PubMed ID: 7816094
[TBL] [Abstract][Full Text] [Related]
8. Therapy other than reverse transcriptase inhibitors for HIV infection.
Kaplan JC; Hirsch MS
Clin Lab Med; 1994 Jun; 14(2):367-91. PubMed ID: 7523020
[TBL] [Abstract][Full Text] [Related]
9. HIV replication.
Kingman S
Mol Med Today; 1995 Apr; 1(1):2. PubMed ID: 9415128
[No Abstract] [Full Text] [Related]
10. Antigen presentation and related immunological aspects of HIV-1 vaccines.
Steinman RM; Germain RN
AIDS; 1998; 12 Suppl A():S97-112. PubMed ID: 9632991
[No Abstract] [Full Text] [Related]
11. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
[TBL] [Abstract][Full Text] [Related]
12. Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.
Kousignian I; Abgrall S; Grabar S; Mahamat A; Teicher E; Rouveix E; Costagliola D;
Clin Infect Dis; 2008 Jan; 46(2):296-304. PubMed ID: 18171266
[TBL] [Abstract][Full Text] [Related]
13. Questions about HIV causing AIDS? Viral load and T-cell (CD4) counts: why they really matter.
AIDS Treat News; 2001 May; (364):7-8. PubMed ID: 11569964
[No Abstract] [Full Text] [Related]
14. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
[TBL] [Abstract][Full Text] [Related]
15. The impact of antiretroviral therapy on AIDS and survival.
Lundgren JD; Mocroft A
J HIV Ther; 2006 Jun; 11(2):36-8. PubMed ID: 16981594
[No Abstract] [Full Text] [Related]
16. Biology of HIV-1 and treatment strategies.
Terwilliger EF
Emerg Med Clin North Am; 1995 Feb; 13(1):27-42. PubMed ID: 7851319
[TBL] [Abstract][Full Text] [Related]
17. Paradigms, platitudes, opportunists.
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Nov; 1(10):16-24, 26-9 contd. PubMed ID: 11362971
[TBL] [Abstract][Full Text] [Related]
18. AIDS pathogenesis: a finite immune response to blame?
Miedema F; Klein MR
Science; 1996 Apr; 272(5261):505-6. PubMed ID: 8614796
[No Abstract] [Full Text] [Related]
19. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.
Carcelain G; Tubiana R; Samri A; Calvez V; Delaugerre C; Agut H; Katlama C; Autran B
J Virol; 2001 Jan; 75(1):234-41. PubMed ID: 11119593
[TBL] [Abstract][Full Text] [Related]
20. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.
Hazuda DJ; Young SD; Guare JP; Anthony NJ; Gomez RP; Wai JS; Vacca JP; Handt L; Motzel SL; Klein HJ; Dornadula G; Danovich RM; Witmer MV; Wilson KA; Tussey L; Schleif WA; Gabryelski LS; Jin L; Miller MD; Casimiro DR; Emini EA; Shiver JW
Science; 2004 Jul; 305(5683):528-32. PubMed ID: 15247437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
